The Venture Codex Logo

The Venture Codex

Overview

Genetic disorder treatment for ventricular repolarization issues.

Total Raised

$19 M

Rounds

1

Links

Verticals

Biotechnology
Precision Medicine
Therapeutics

Investment History

  1. Series A

    Aug 2021

    $19M

Team

Paul F. Truex

CEO,Co-Founder & Chairman

Renee Martin

Chief Scientific Officer

Philip Sager

CMO

Debra Odink

Chief Development Officer